The contribution of 2-AG-CB1 signaling to the extinction of conditioned fear responses has led to extensive research into the pharmacological augmentation of 2-AG for its therapeutic potential in the treatment of anxiety disorders, including PTSD with conflicting results [19,20,21,22,23,24,25,26,27,28]. The gene discussed is CNR1; the disease is post-traumatic stress disorder.